Noto v. 22nd Century Grp. ( 2022 )


Menu:
  • 21-0347-cv
    Noto v. 22nd Century Grp.
    In the
    United States Court of Appeals
    For the Second Circuit
    ________
    AUGUST TERM 2021
    ARGUED: SEPTEMBER 2, 2021
    DECIDED: MAY 24, 2022
    No. 21-0347-cv
    Joseph Noto, Garden State Tire Corp., Stephens Johnson,
    Individually and on Behalf of All Others Similarly Situated,
    Plaintiffs-Appellants,
    v.
    22nd Century Group, Inc., Henry Sicignano, III, John T. Brodfuehrer,
    Defendants-Appellees.
    ________
    Appeal from the United States District Court
    for the Western District of New York
    ________
    Before: WALKER, CALABRESI, AND LOHIER, Circuit Judges.
    ________
    Plaintiffs Joseph Noto, Stephens Johnson, and Garden State
    Tire Corporation appeal from a judgment of the United States District
    Court for the Western District of New York (Sinatra, J.) dismissing
    their complaint against 22nd Century Group and its former CEO and
    CFO, Henry Sicignano, III and John T. Brodfuehrer.         Plaintiffs,
    2                                                         No. 21-0347-cv
    investors in 22nd Century Group, allege on behalf of an investor class
    that (1) defendants engaged in an illegal stock promotion scheme in
    which they paid authors to write promotional articles about the
    company while concealing the fact that they paid the authors for the
    articles; and (2) defendants failed to disclose an investigation by the
    Securities and Exchange Commission into the company’s financial
    control weaknesses. After public articles revealed the promotion
    scheme and SEC investigation, the company’s stock price fell, and
    plaintiffs allege they were harmed. The complaint was dismissed by
    the district court for failing to state a claim upon which relief could be
    granted.
    On appeal, plaintiffs argue that (1) they adequately alleged
    material misrepresentations and manipulative acts sufficient to
    sustain claims under subsections (a), (b), and (c) of SEC Rule 10b-5;
    (2) their claim under § 20(a) of the Securities Exchange Act was
    premised on a valid predicate violation of § 10(b); and (3) the district
    court erred in dismissing the complaint with prejudice. On the first
    and second points, we agree that the allegation that defendants failed
    to disclose the SEC investigation states a material misrepresentation
    and could also support § 20(a) liability. We find no merit in the
    remaining challenges. Accordingly, we AFFIRM in part, VACATE
    in part, and REMAND for further proceedings consistent with this
    opinion.
    ________
    JEREMY A. LIEBERMAN, Pomerantz LLP, New York,
    NY, for Plaintiffs-Appellants
    JOHN A. TUCKER (Jonathan H. Friedman, on the
    brief), Foley & Lardner LLP, Jacksonville, FL, New
    York, NY; Charles C. Ritter, Jr., on the brief, Duke,
    3                                                       No. 21-0347-cv
    Holzman, Photiadis & Gresens LLP, Buffalo, NY,
    for Defendants-Appellees
    ________
    JOHN M. WALKER, JR., Circuit Judge:
    Plaintiffs Joseph Noto, Stephens Johnson, and Garden State
    Tire Corporation appeal from a judgment of the Western District of
    New York (Sinatra, J.) dismissing their complaint against 22nd
    Century Group and its former CEO and CFO, Henry Sicignano, III
    and John T. Brodfuehrer. Plaintiffs, investors in 22nd Century Group,
    allege on behalf of an investor class that (1) defendants engaged in an
    illegal stock promotion scheme in which they paid authors to write
    promotional articles about the company while concealing the fact that
    they paid the authors for the articles; and (2) defendants failed to
    disclose an investigation by the Securities and Exchange Commission
    (“SEC”) into the company’s financial control weaknesses.          After
    public articles revealed the promotion scheme and SEC investigation,
    the company’s stock price fell, and plaintiffs allege they were harmed.
    The complaint was dismissed by the district court for failing to state
    a claim upon which relief could be granted.
    On appeal, plaintiffs argue that (1) they adequately alleged
    material misrepresentations and manipulative acts sufficient to
    sustain claims under subsections (a), (b), and (c) of SEC Rule 10b-5;
    (2) their claim under § 20(a) of the Securities Exchange Act was
    premised on a valid predicate violation of § 10(b); and (3) the district
    court erred in dismissing the complaint with prejudice. On the first
    and second points, we agree that the allegation that defendants failed
    to disclose the SEC investigation states a material misrepresentation
    and could also support § 20(a) liability. We find no merit in the
    remaining challenges. Accordingly, we AFFIRM in part, VACATE
    4                                                              No. 21-0347-cv
    in part, and REMAND for further proceedings consistent with this
    opinion.
    BACKGROUND
    The corporate defendant, 22nd Century Group, Inc. (“22nd
    Century” or “the Company”), is a publicly traded company that
    strives to genetically engineer tobacco and cannabis plants to regulate
    their nicotine levels or cannabinoids. From 2015 to 2019, Henry
    Sicignano, III was the Company’s CEO, and from 2013 to 2019, John
    T. Brodfuehrer was the Company’s CFO. Shortly after Sicignano
    became CEO, he engaged the consulting firm IRTH Communications
    (“IRTH”) to handle 22nd Century’s investor relations. For purposes
    of this appeal, we accept as true the following allegations in the
    complaint. 1
    I.     Stock Promotion Scheme
    Confidential Witness 1 (“CW1”), Sicignano’s executive
    assistant from January 2016 to February 2018, worked directly with
    Sicignano and interacted frequently with Brodfuehrer. CW1 saw
    Sicignano review and approve the Company’s press releases. In
    February and March 2017, Sicignano told CW1 several times that he
    was “working behind the scenes” to prop up 22nd Century’s stock
    price because the Company “did not have enough cash to operate for
    much longer.” 2 The same year, Brodfuehrer repeatedly told CW1
    that, because he had concerns about Sicignano’s conduct, he was not
    comfortable signing the Company’s SEC filings.
    From February 2017 through October 2017, various writers
    published positive online articles about the prospects for 22nd
    1
    Palin v. N.Y. Times Co., 
    940 F.3d 804
    , 809 (2d Cir. 2019).
    2 Joint App. at 32–33.
    5                                                       No. 21-0347-cv
    Century’s stock.       Many articles repeated statements from the
    Company’s press releases, the FDA’s press releases, and Sicignano on
    earnings calls, in presentations, and at conferences. Defendants paid
    the writers directly, or indirectly through IRTH, to publish the
    articles.    The articles did not reveal that the Company was
    compensating the writers.
    Based on his conversations with Sicignano, CW1 “came to
    understand that Sicignano and the Company were paying for writers
    to write articles disguised as [] legitimate articles that just promoted
    [the Company’s] stock” but which were not identified as stock
    promotion articles. 3 Based on Sicignano’s comments, it was “clear”
    to CW1 that Sicignano knew that paying third parties to write
    promotional articles without disclosing that the Company had paid
    for them was inappropriate. 4 CW1 stated that he was “sure” that
    Sicignano “reviewed, edit[ed], and/or approv[ed]” the paid stock
    promotion articles “because Sicignano was intensely focused on
    everything that was said publicly about the Company and ‘went over
    every Company press release with a fine-toothed comb.’” 5
    On multiple occasions, after the articles were published, 22nd
    Century’s stock price rose. From February 2017 until October 2017,
    the stock price more than tripled. On October 10, 2017, the Company
    closed a registered direct common stock offering that yielded $50.7
    million in net proceeds.
    Then, in the Company’s annual 2017 Form 10-K submitted in
    March 2018 to the SEC, the Company reported that it had sufficient
    cash on hand to sustain normal operations for several years. The 2017
    10-K, as well as the other 10-Ks filed in the class period, also stated
    3
    Joint App. at 33–34.
    4 Joint App. at 34.
    5 Joint App. at 34.
    6                                                         No. 21-0347-cv
    that the Company’s stock price was subject to volatility and listed 19
    factors that, “in addition to other risk factors . . . may have a
    significant impact on” its stock price. 6
    II.     SEC Investigation
    In February 2016, defendants filed the Company’s 2015 10-K.
    That 10-K disclosed that the Company’s management had concluded
    that its “internal controls over financial reporting were not effective
    and that material weaknesses exist[ed] in [its] internal control over
    financial reporting” as it related to segregation of duties. 7         To
    ameliorate these weaknesses, defendants hired an accounting
    manager, Confidential Witness 2 (“CW2”), who reported directly to
    CFO Brodfuehrer. In its SEC Forms 10-Q for the first, second, and
    third quarters of 2016, as well as its 2016 10-K, the Company repeated
    that its financial reporting controls and procedures were not effective
    and noted that it was undertaking remediation efforts. 8 Ultimately,
    in its Form 10-Q for the second quarter of 2018, the Company stated
    that it had “completed the implementation and testing of a
    remediation plan that was targeted at eliminating our previously
    reported material weakness in our internal controls over financial
    reporting primarily resulting from a lack of segregation of duties.” 9
    According to CW2, the SEC was investigating the Company at
    the time he was hired in 2016. CW2 stated that the investigation
    continued throughout 2016, and that, by the time he left in 2019, he
    had not seen any statement from the SEC formally closing the
    investigation.     The Company retained counsel to represent it in
    Joint App. at 62–65.
    6
    7 Joint App. at 27.
    8 The complaint makes no mention here of SEC filings for 2017. See Joint
    App. at 76–77.
    9 Joint App. at 27.
    7                                                     No. 21-0347-cv
    connection with the investigation, and, in 2016, Brodfuehrer traveled
    to Washington, D.C. to meet with the SEC. Brodfuehrer told CW2
    that he feared that the investigation could cost Brodfuehrer his CPA
    license or lead to his imprisonment. The SEC investigation was
    underway throughout the time that the Company was disclosing its
    ineffective financial reporting controls.
    On July 16, 2018, the SEC received a nonpublic Freedom of
    Information Act (“FOIA”) request seeking “all documents in the
    [SEC’s] possession . . . pertaining to investigations regarding [the
    Company] for the time period January 1, 2016 through July 16,
    2018.” 10 On August 13, 2018, a FOIA Officer denied the request
    pursuant to the FOIA exemption that authorizes the withholding of
    “records or information compiled for law enforcement purposes, but
    only to the extent that production of such law enforcement records or
    information . . . could reasonably be expected to interfere with
    enforcement proceedings.” 11 The SEC Office of the General Counsel
    affirmed the denial.
    III.   The Public Revelations
    On February 2, 2018, an online commentator, “Fuzzy Panda”
    posted an online article that claimed that 22nd Century engaged in a
    paid stock promotion scheme to illegally inflate its share price. The
    Company’s stock price fell by 16.9%. On October 25, 2018, Fuzzy
    Panda posted a second article that disclosed the FOIA request denial
    and suggested that the SEC was investigating the Company. The
    article also suggested that the Company had paid undisclosed
    promoters to pump up its stock price in advance of the October 2017
    stock offering. The next day, the Company’s stock price fell by 4.3%.
    10
    Joint App. at 55.
    11 Joint App. at 55–56 (ellipses in original).
    8                                                        No. 21-0347-cv
    In response, on October 26, 2018, the Company, for the first
    time, broke its silence about the SEC investigation. But it did so by
    denying any knowledge of an “enforcement proceeding.”                The
    Company issued a press release saying the October 25 article was
    “highly deceptive” and that the Company “has not received any
    notice of, and the Company has no knowledge of, any enforcement
    proceeding against [the Company] by the SEC or any other
    regulator.” 12
    On April 17, 2019, Fuzzy Panda posted a third article, repeating
    the undisclosed stock promoters and SEC investigation allegations.
    The Company’s stock price fell again. The next day, the Company
    issued another statement denying both the illegal stock promotion
    and SEC investigation claims, stating that the article “falsely alleges
    that [the Company] is supposedly under SEC investigation.” 13
    On July 26, 2019, the Company announced that Sicignano had
    resigned as CEO for “personal reasons” but would continue to act as
    a consultant to the Company. 14 The Company’s stock price fell in the
    days following the announcement.          On December 3, 2019, CFO
    Brodfuehrer retired.
    IV.     Procedural History
    In November 2019, after this case was transferred to the
    Western District of New York, plaintiffs filed the amended class
    action complaint at issue in this appeal. The class consisted of any
    person or entity that acquired 22nd Century securities between
    February 18, 2016, and July 31, 2019.
    On May 1, 2020, defendants moved to dismiss the amended
    12
    Joint App. at 57.
    13 Joint App. at 59.
    14 Joint App. at 60.
    9                                                           No. 21-0347-cv
    complaint for failure to state a claim. Plaintiffs asked the district court
    for an opportunity to further amend the complaint should the court
    grant any part of defendants’ motion. On January 14, 2021, the district
    court dismissed the entirety of the amended complaint with prejudice
    and denied plaintiffs’ request for leave to amend as futile.
    This appeal followed.
    DISCUSSION
    We review the grant of a motion to dismiss de novo. 15 To
    survive a motion to dismiss under Federal Rule of Civil Procedure
    12(b)(6), the complaint must contain sufficient factual matter,
    accepted as true, to “state a claim to relief that is plausible on its
    face.” 16   “The plausibility standard is not akin to a probability
    requirement, but it asks for more than a sheer possibility that a
    defendant has acted unlawfully.” 17 In evaluating a complaint, the
    court draws all reasonable inferences in the plaintiff’s favor. 18 But the
    court is free to disregard conclusory allegations or legal conclusions
    couched as factual allegations. 19
    We also review de novo a district court’s denial of leave to
    amend when denial is based on a legal interpretation, such as the
    conclusion that amendment would be futile. 20
    15
    Ganino v. Citizens Utils. Co., 
    228 F.3d 154
    , 161 (2d Cir. 2000).
    16
    Ashcroft v. Iqbal, 
    556 U.S. 662
    , 678 (2009) (internal quotation marks
    omitted).
    17 
    Id.
     (internal quotation marks omitted).
    18 Palin, 940 F.3d at 809.
    19 Dixon v. von Blanckensee, 
    994 F.3d 95
    , 101 (2d Cir. 2021) (internal
    quotation marks omitted).
    20 Hutchison v. Deutsche Bank Sec. Inc., 
    647 F.3d 479
    , 490 (2d Cir. 2011).
    10                                                           No. 21-0347-cv
    I.        Rule 10b-5(b) Claims
    The complaint alleges that defendants violated § 10(b) of the
    Exchange Act 21 and SEC Rule 10b-5(b). 22            Plaintiffs claim that
    defendants unlawfully published promotional articles and concealed
    an SEC investigation, all in an effort to artificially inflate the
    Company’s stock price. Plaintiffs contend that when these infractions
    were brought to light, the stock price fell.
    Under Rule 10b-5(b), it is “unlawful for any person, directly or
    indirectly, . . . [t]o make any untrue statement of a material fact or to
    omit to state a material fact necessary in order to make the statements
    made, in light of the circumstances under which they were made, not
    misleading” in connection with the purchase or sale of securities. 23 To
    support a claim for material misrepresentation under that rule, a
    plaintiff must plead: (1) a material misrepresentation or omission, (2)
    scienter, (3) a connection between the misrepresentation or omission
    and the purchase or sale of a security, (4) reliance on the
    misrepresentation or omission, (5) economic loss, and (6) loss
    causation. 24 The first two elements must be pled with heightened
    specificity pursuant to the Private Securities Litigation Reform Act of
    1995 and Federal Rule of Civil Procedure 9(b). 25
    A.     Stock Promotion Scheme
    The complaint alleges that defendants omitted the material fact
    that they were paying authors to promote the Company’s stock. The
    15 U.S.C. § 78j.
    21
    
    17 C.F.R. § 240
    .10b-5.
    22
    23 
    Id.
    24 Janus Cap. Grp., Inc. v. First Derivative Traders, 
    564 U.S. 135
    , 140 n.3
    (2011).
    25 See 15 U.S.C. § 78u-4(b); Rombach v. Chang, 
    355 F.3d 164
    , 170 (2d Cir.
    2004).
    11                                                              No. 21-0347-cv
    district court found that defendants had no duty to disclose that fact
    and therefore made no material omission.
    On appeal, plaintiffs first argue that defendants had a duty to
    disclose that the Company and IRTH paid the authors of the
    promotional articles because defendants provided content for, edited,
    reviewed, and/or approved those articles. But only an article’s maker,
    not its benefactor, has a duty to disclose that it was paid for. 26 And
    the Supreme Court has made clear that neither the Company nor the
    individual defendants qualify as a maker here. In Janus Capital Group
    v. First Derivative Traders, the Court held that a mutual fund
    investment advisor could not be held liable for misstatements
    included in its client mutual funds’ prospectuses. 27 “For purposes of
    Rule 10b-5, the maker of a statement is the person or entity with
    ultimate authority over the statement, including its content and
    whether and how to communicate it.” 28 Thus, because the mutual
    funds filed the prospectuses with the SEC and had ultimate control
    over their content, they were the makers of the statements in the
    prospectuses. The investment advisor, even if he was involved in the
    preparation of the prospectuses, was not. 29
    26Janus, 
    564 U.S. at 141
     (“Under Rule 10b-5, it is unlawful for any person,
    directly or indirectly, to make any untrue statement of a material
    fact . . . . To be liable, therefore, [a defendant] must have ‘made’ the material
    misstatements . . . .” (internal quotation marks and alterations omitted)).
    27 
    Id.
     at 137–38.
    28 
    Id. at 142
    .
    29 
    Id.
     at 147–48.
    This finding is buttressed by Section 17(b) of the
    Securities Act, which provides that “[i]t shall be unlawful for any
    person . . . to         publish,      give    publicity    to,   or      circulate
    any . . . article . . . which . . . describes [a] security for a consideration
    received or to be received, directly or indirectly, from an issuer . . . without
    fully disclosing the receipt . . . of such consideration.” 15 U.S.C. § 77q(b)
    (emphasis added). Again, only the publisher or author—the maker—of
    12                                                          No. 21-0347-cv
    The complaint does not adequately allege that defendants had
    ultimate control over the articles. It contains conclusory statements
    that “[d]efendants furnished information and language for, prepared,
    reviewed, approved, and/or ratified the articles,” 30 but does not
    contain sufficient factual allegations to support that contention. To be
    sure, the complaint alleges that Sicignano reviewed and approved
    statements in the Company’s press releases, 31 which were then often
    copied and repeated by the promotional articles. 32 But a person’s
    preparation of a press release that is then repeated in a separate article
    by a different author does not qualify that person as the “maker” of
    the separate article’s statements. The Supreme Court specifically
    rejected a holding that would allow plaintiffs “to sue a person who
    ‘provides the false or misleading information that another person
    then puts into [a] statement.’” 33 The complaint does not adequately
    allege that Sicignano directly wrote the articles, controlled what the
    authors put into the articles, or even saw them before their
    publication. “Threadbare recitals of the elements of a cause of action,
    supported by mere conclusory statements,” are insufficient to state a
    claim. 34
    Moreover, even if Sicignano had provided some input on the
    content of the articles, the complaint does not support the conclusion
    that Sicignano had the “ultimate authority” necessary to brand him
    such articles can be liable under § 17(b) for failing to disclose that he has
    been paid for the article.
    30 Joint App. at 35.
    31 Joint App. at 35.
    32 See, e.g., Joint App. 46–47.
    33 Janus, 
    564 U.S. at
    144–45 (internal quotation marks omitted).
    34 Iqbal, 
    556 U.S. at 678
    .
    13                                                               No. 21-0347-cv
    the articles’ maker. 35      The complaint made no sufficient factual
    allegation that the articles were published by anyone except the
    authors. Nor did it sufficiently allege that those authors lacked final
    control over the articles’ contents or did not make the ultimate
    decision as to what specific information to include. The complaint
    also does not contain sufficient factual allegations that defendants
    collaborated with the authors to such an extent that they controlled
    the articles’ publication. 36        Here, any such inference is pure
    speculation.
    Plaintiffs next contend that defendants had a duty to disclose
    the article payments because defendants, in their SEC filings,
    affirmatively warned investors of the volatility of the Company’s
    stock price. This argument also fails.
    “Silence, absent a duty to disclose, is not misleading under Rule
    10b-5.” 37 Rule 10b-5(b), however, makes unlawful the omission of a
    material fact “necessary in order to make the statements made, in the
    light of the circumstances under which they were made, not
    misleading.” 38      Thus, disclosure is required when a corporate
    statement       would    otherwise      be   “inaccurate,      incomplete,      or
    35
    See Janus, 
    564 U.S. at
    142–43 (noting that “[e]ven when a speechwriter
    drafts a speech, the content is entirely within the control of the person who
    delivers it,” and so the speaker, but not the speechwriter, is its maker).
    36 Cf. In re Pfizer Inc. Sec. Litig., 
    819 F.3d 642
    , 657 (2d Cir. 2016) (finding
    that there was a genuine dispute as to whether Pfizer had ultimate
    authority over statements given by another company’s employees because
    of a fax that stated that Pfizer and the other company each had to give final
    sign-off on statements given by those employees).
    37 Basic Inc. v. Levinson, 
    485 U.S. 224
    , 239 n.17 (1988); see also Stratte-
    McClure v. Morgan Stanley, 
    776 F.3d 94
    , 101 (2d Cir. 2015) (“[A]n omission
    is actionable under the securities laws only when the corporation is subject
    to a duty to disclose the omitted facts.” (quotation omitted)).
    38 
    17 C.F.R. § 240
    .10b-5(b).
    14                                                                No. 21-0347-cv
    misleading.” 39      In the Company’s 2015-2017 10-Ks, defendants
    disclosed 19 different factors that could lead to stock price volatility
    but did not include its paid stock promotion scheme on the list. 40
    Notably, under § 17(b) of the Securities Act of 1933, an issuer
    who merely pays an author to write positive articles on a stock does
    not, without more, violate the Act. 41 The articles themselves did little
    more than republish publicly-available content. Moreover, there is no
    allegation that the press releases, the content of which was captured
    in the articles themselves, were false or misleading.
    Because the complaint does not adequately allege that
    defendants had a duty to disclose that they paid for the articles’
    publication, plaintiffs fail to state a claim that the existence of the stock
    promotion scheme constituted a materially misleading omission.
    B.    SEC Investigation
    The complaint next alleges that defendants violated Rule 10b-
    5(b) by failing to disclose the SEC investigation into the Company’s
    accounting controls. The district court found that defendants had no
    duty to disclose the investigation. Plaintiffs contend that defendants
    had such a duty because, by not mentioning the investigation, their
    disclosures of the accounting deficiencies were misleading. Here we
    agree with plaintiffs.
    According to the complaint, throughout 2016 to 2018, the
    Company’s 10-Ks and 10-Qs reported material weaknesses in its
    internal financial controls, until one 2018 10-Q reported that the
    Company had completed the implementation and testing of a
    Glazer v. Formica Corp., 
    964 F.2d 149
    , 157 (2d Cir. 1992).
    39
    40 See, e.g., Joint App. at 62–65.
    41 See 15 U.S.C. § 77q(b); In re Galectin Therapeutics, Inc. Sec. Litig., 
    843 F.3d 1257
    , 1272–73 (11th Cir. 2016).
    15                                                             No. 21-0347-cv
    remediation plan targeted at eliminating those weaknesses.42
    Relatedly, at some point prior to CW2’s hiring in 2016, the SEC
    opened an investigation into the Company. 43 The Company retained
    counsel and CFO Brodfuehrer traveled to Washington, D.C. to meet
    with the SEC. 44 Then, in 2018, the SEC responded to a FOIA request
    by stating that its disclosure of information about any investigations
    into the Company from 2016 to 2018 “could reasonably be expected
    to interfere with enforcement proceedings.” 45 After Fuzzy Panda
    published the SEC’s response, the Company publicly denied any
    notice of an investigation or enforcement proceeding against it.
    Defendants had a duty to disclose the SEC investigation in light
    of the specific statements they made about the Company’s accounting
    weaknesses. 46 “Even when there is no existing independent duty to
    disclose information, once a company speaks on an issue or topic,
    there is a duty to tell the whole truth.” 47 An omission is material when
    a reasonable investor would attach importance to it when making a
    decision. 48 Here, the fact of the SEC investigation would directly bear
    on the reasonable investor’s assessment of the severity of the reported
    accounting weaknesses. Thus, the Company had a duty to disclose
    the SEC investigation into the weaknesses throughout the class
    period. 49 Because defendants here specifically noted the deficiencies
    Joint App. at 27, 78–79.
    42
    Joint App. at 27–28.
    43
    44 Joint App. at 28.
    45 Joint App. at 55–56.
    46 See Setzer v. Omega Healthcare Invs., Inc., 
    968 F.3d 204
    , 214 n.15 (2d Cir.
    2020) (noting that Rule 10b-5 imposes a duty to disclose not “all the facts
    that pertain to a subject,” but rather only material facts).
    47 Meyer v. Jinkosolar Holdings Co., 
    761 F.3d 245
    , 250 (2d Cir. 2014).
    48 See Ganino, 
    228 F.3d at
    161–62.
    49 See Caiola v. Citibank, N.A., 
    295 F.3d 312
    , 331 (2d Cir. 2002) (“[U]pon
    choosing to speak, one must speak truthfully about material issues. Once
    16                                                            No. 21-0347-cv
    and that they were working on the problem, and then stated that they
    had solved the issue, “the failure to disclose [the investigation] would
    cause a reasonable investor to make an overly optimistic assessment
    of the risk.” 50
    Throughout this period, the existence of an SEC investigation
    related to the accounting weaknesses was material information that a
    reasonable investor would have wanted to know.                   Indeed, the
    nondisclosure remained a material omission even after the Company
    represented that it had rectified the problem because the SEC
    investigation was ongoing.         By not disclosing that the SEC was
    investigating      the   Company’s      specific    accounting      weakness,
    defendants’ statements about that weakness were not accurate and
    complete.
    Finally, defendants’ false public denial of any knowledge of the
    SEC investigation amounts to an admission of the materiality of its
    nondisclosure. Otherwise, the Company would not have tried to hide
    it. Moreover, these denials were affirmatively misleading in their
    own right. Thus, we easily find that the complaint adequately alleged
    that defendants violated Rule 10b-5(b) both by first omitting mention
    of the SEC investigation and then by affirmatively denying its
    existence. 51
    Citibank chose to discuss its hedging strategy, it had a duty to be both
    accurate and complete.” (internal citations omitted)).
    50 Jinkosolar, 761 F.3d at 251.
    51 Defendants argue that plaintiffs’ § 10(b) material misrepresentation
    claims also should be dismissed for the additional reasons that the
    complaint fails to adequately plead scienter and loss causation. But the
    district court declined to consider those arguments. Noto v. 22nd Century
    Grp., Inc., 
    2021 WL 131050
    , at *2 n.1 (W.D.N.Y. Jan. 14, 2021). “It is this
    Court’s usual practice to allow the district court to address arguments in
    the first instance.” Eric M. Berman, P.C. v. City of New York, 
    796 F.3d 171
    , 175
    17                                                           No. 21-0347-cv
    II.      Rule 10b-5(a) and (c) Claims
    The complaint next alleges that defendants violated Rule 10b-
    5, specifically subsections (a) and (c), by illegally manipulating the
    market through the stock promotion scheme. 52 The district court
    found that the complaint did not adequately allege a manipulative act
    or market activity sufficient to state a claim under those rules. We
    agree.
    To state a claim for market manipulation under § 10(b) and
    Rules 10b-5(a) and (c), a plaintiff must allege: “(1) manipulative acts;
    (2) damage (3) caused by reliance on an assumption of an efficient
    market free of manipulation; (4) scienter; (5) in connection with the
    purchase or sale of securities; (6) furthered by the defendant’s use of
    the mails or any facility of a national securities exchange.”53
    Manipulation “connotes intentional or willful conduct designed to
    deceive or defraud investors by controlling or artificially affecting the
    price of securities.” 54 Accordingly, “[t]he critical question [is] what
    activity ‘artificially’ affects a security’s price in a deceptive manner.”55
    A court must ask whether a defendant injected inaccurate information
    into the marketplace. 56
    The complaint fails to support a claim that defendants
    manipulated the market. It does not allege that the market was
    manipulated by either the information in the articles, the payments to
    the writers, or the non-disclosure of the payments.             There is no
    (2d Cir. 2015) (per curiam) (quotation and alteration omitted). Accordingly,
    we do not address them here.
    52 The complaint does not base this claim on the non-disclosure of the
    SEC investigation.
    53 ATSI Commc’ns, Inc. v. Shaar Fund, Ltd., 
    493 F.3d 87
    , 101 (2d Cir. 2007).
    54 Ernst & Ernst v. Hochfelder, 
    425 U.S. 185
    , 199 (1976).
    55 ATSI, 
    493 F.3d at 100
    .
    56 
    Id. at 101
    .
    18                                                          No. 21-0347-cv
    allegation that the articles themselves, which consisted of analysis
    and information derived from public filings, press releases, and
    statements by management, manipulated the market.                Relatedly,
    there is no claim that defendants paying the articles’ authors
    somehow manipulated the market or was intentionally designed to
    do so. While plaintiffs argue that the non-disclosure of defendants’
    payments to the authors was materially misleading to investors (the
    point addressed—and rejected in Part I), that, in and of itself, does not
    equate to market manipulation. 57 There is therefore no allegation that
    defendants affirmatively “injected” inaccurate information into the
    market:       even if the payments were material, which we have
    determined not to be the case, because defendants were not the
    articles’ “makers,” they had no responsibility for the payments’
    disclosure. And there is no allegation that defendants directed the
    authors not to disclose the payments, or that defendants were
    anything but indifferent as to whether the authors did so. Thus,
    plaintiffs fail to plead that defendants engaged in any manipulative act
    sufficient to sustain a market manipulation claim based on the
    undisclosed payments.
    III.    Section 20(a) Claim
    The complaint also alleges that Sicignano and Brodfuehrer are
    liable under the control person provision of § 20(a) of the Exchange
    Act. To state a claim under § 20(a), a plaintiff must demonstrate, inter
    alia, a primary violation by the controlled person. 58
    The district court held that, because plaintiffs failed to plead a
    primary violation under § 10(b) and Rule 10b-5, the dependent § 20(a)
    claims must necessarily fail. Because we remand the § 10(b) material
    Id. (“A market manipulation claim [] cannot be based solely upon
    57
    misrepresentations or omissions.”).
    58 Id. at 108.
    19                                                              No. 21-0347-cv
    misrepresentation claim based on the non-disclosure of the SEC
    investigation, we also vacate the § 20(a) claim dismissal solely as it
    pertains to that particular non-disclosure.
    IV.     Leave to Amend
    At the conclusion of their opposition to the motion to dismiss,
    plaintiffs requested an opportunity to amend their complaint should
    any part of defendants’ motion be granted. The district court denied
    the request. 59      While we remand on the dismissal of the SEC
    investigation non-disclosure aspect of plaintiffs’ Rule 10b-5(b) claim,
    we agree that plaintiffs should not be permitted to amend their
    complaint to reallege any violations stemming from the non-
    disclosure of the article promotion scheme.
    “[T]his circuit strongly favors liberal grant of an opportunity to
    replead after dismissal of a complaint under Rule 12(b)(6).” 60 But a
    court need not always allow a party to replead simply because it
    asked. In particular, denial of leave to amend is proper “where the
    request gives no clue as to how the complaint’s defects would be
    cured.” 61 That is the situation here. In their briefing on appeal,
    plaintiffs contend that they could “cure any deficiencies with
    additional testimony . . . about [d]efendants’ editing, review, and
    approval” of the promotional articles, but do not allege what specific
    facts they would include to demonstrate the level of control needed
    for Rule 10b-5(b) liability. 62 And, at oral argument, plaintiffs’ counsel
    conceded that plaintiffs did not presently have any additional facts
    Noto, 
    2021 WL 131050
    , at *2 n.2.
    59
    Porat v. Lincoln Towers Cmty. Ass’n, 
    464 F.3d 274
    , 276 (2d Cir. 2006) (per
    60
    curiam).
    61 Loreley Fin. (Jersey) No. 3 Ltd. v. Wells Fargo Sec., LLC, 
    797 F.3d 160
    , 190
    (2d Cir. 2015) (internal quotation marks omitted).
    62 Appellants’ Br. at 54.
    20                                                           No. 21-0347-cv
    regarding defendants’ control not already included in the
    complaint. 63 Plaintiffs also did not explain what they would add to
    demonstrate how defendants engaged in market manipulation
    related to the articles.            The district court thus properly denied
    plaintiffs’ request to replead their allegations stemming from the
    stock promotion scheme.
    CONCLUSION
    For the foregoing reasons, we AFFIRM in part and VACATE in
    part the judgment of the district court and REMAND for further
    proceedings consistent with this opinion.
    63   Oral Arg. Tr. at 31–32.